Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
   61  Antibiotics
     611  Acting mainly on gram-positive bacteria
     612  Acting mainly on gram-negative bacteria
       6121  Penicillins
       6122  Monobactams
       6123  Amino sugars
         D00866  Kanamycin sulfate (USP); Kanamycin monosulfate (JP18)
         D00865  Amikacin sulfate (JP18/USP)
         D00063  Tobramycin (JP18/USP)
         D01826  Isepamicin sulfate (JP18)
       6124  Spectinomycins
       6125  Colistins
       6126  Polymyxin B
       6129  Others
     613  Acting mainly on gram-positive and gram-negative bacteria
     614  Acting mainly on gram-positive bacteria and mycoplasma
     615  Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia
     616  Acting mainly on acid-fast bacteria
     617  Acting mainly on mold
     619  Miscellaneous
   62  Chemotherapeutics
   63  Biological preparations
   64  Parasitics (systemic)
   69  Other agents against pathogenic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: March 19, 2024
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version